NCT05496231 2025-02-03A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of AgeGlaxoSmithKlinePhase 1/2 Completed1,080 enrolled 28 charts
NCT00064311 2012-03-08Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed